NCT06239116Phase 1, phase 2Active not recruiting

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

Study sponsor: Rhythm Pharmaceuticals, Inc. · RYTM

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-05-07Estimated
Enrollment · participants111Actual
Source updated2026-10-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.